Vancouver BC / TheNewswire / January 29, 2019.  Izotropic Corporation (CSE: IZO) is reporting the cancellation of the stock options to the following consultants who are no longer engaged by the Company: Robert Lunde was issued 100,000 Options on October 10, 2018 with an exercise price of $0.40 for one year, and; Peymon Gazi was issued 200,000 Options on September 20, 2017 with an exercise price of $0.10 for a period of five years. These two options are now cancelled.

   

About Izotropic Corp.

The company is engaged in the development and commercialization of next-generation, 3-D breast CT imaging technology for early diagnosis of breast cancer, that improves patient comfort, provides a true 360-degree-view acquisition and delivers high diagnostic accuracy.

The company has also established a wholly owned U.S subsidiary called Isotropic Imaging Corp in 2016 to advance the company’s breast imaging development.

Phone: 1-833-IZOCORP
Email: info@izocorp.com
Website: www.izocorp.com